this should be the best 1/4 yet for growth
But still a long way to cash neutral
- Forums
- ASX - By Stock
- Ann: DyeVert Clinical Data Featured at US Scientific Conferences
this should be the best 1/4 yet for growthBut still a long way...
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)